NRSN·M74240108·US·Common Stock·Healthcare - Biotechnology
NRSN (NEUROSENSE THERAPEUTICS LTD) is held by 9 institutional investors as of Q1 2026. Largest holders: UBS Group AG ($37,067), TWO SIGMA INVESTMENTS, LP ($33,556), JANE STREET GROUP, LLC ($21,646). Net institutional sentiment: Mixed.
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer